Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.742,18
-0,24%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TG Therapeutics Inc (TGTX) TG Therapeutics Inc (TGTX) Notizie

TGTX

TG Therapeutics (TGTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TGTX
DataOraFonteTitoloSimboloCompagnia
01/05/202413:00GlobeNewswire Inc.TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:TGTXTG Therapeutics Inc
30/04/202422:55GlobeNewswire Inc.TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business UpdateNASDAQ:TGTXTG Therapeutics Inc
18/04/202413:30GlobeNewswire Inc.TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
18/04/202413:00GlobeNewswire Inc.TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple SclerosisNASDAQ:TGTXTG Therapeutics Inc
15/04/202413:30GlobeNewswire Inc.TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
08/03/202413:30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
01/03/202413:30GlobeNewswire Inc.TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual ForumNASDAQ:TGTXTG Therapeutics Inc
29/02/202423:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TGTXTG Therapeutics Inc
28/02/202413:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TGTXTG Therapeutics Inc
28/02/202413:00GlobeNewswire Inc.TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:TGTXTG Therapeutics Inc
27/02/202413:30GlobeNewswire Inc.TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)NASDAQ:TGTXTG Therapeutics Inc
26/02/202413:00GlobeNewswire Inc.TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)NASDAQ:TGTXTG Therapeutics Inc
23/02/202413:30GlobeNewswire Inc.TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business UpdateNASDAQ:TGTXTG Therapeutics Inc
20/02/202413:30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual ForumNASDAQ:TGTXTG Therapeutics Inc
15/02/202403:53Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:TGTXTG Therapeutics Inc
14/02/202421:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TGTXTG Therapeutics Inc
10/01/202413:00GlobeNewswire Inc.TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated MilestonesNASDAQ:TGTXTG Therapeutics Inc
09/01/202415:20AllPennyStocks.comBiotech Massively Bid Up Before Opening BellNASDAQ:TGTXTG Therapeutics Inc
09/01/202413:00GlobeNewswire Inc.TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune DiseasesNASDAQ:TGTXTG Therapeutics Inc
09/01/202400:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TGTXTG Therapeutics Inc
05/01/202417:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TGTXTG Therapeutics Inc
05/01/202413:30GlobeNewswire Inc.TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TGTXTG Therapeutics Inc
27/11/202313:30GlobeNewswire Inc.TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:TGTXTG Therapeutics Inc
06/11/202323:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TGTXTG Therapeutics Inc
03/11/202312:30GlobeNewswire Inc.TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) ConferenceNASDAQ:TGTXTG Therapeutics Inc
01/11/202312:30GlobeNewswire Inc.TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:TGTXTG Therapeutics Inc
30/10/202312:30GlobeNewswire Inc.TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business UpdateNASDAQ:TGTXTG Therapeutics Inc
12/10/202317:00GlobeNewswire Inc.TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
02/10/202313:30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
22/09/202313:30GlobeNewswire Inc.TG Therapeutics to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:TGTXTG Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TGTX

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network